Novel alkyl-substituted 4-methoxy benzaldehyde thiosemicarbazones: Multi-target directed ligands for the treatment of Alzheimer's disease
Authors:
- 30 August 2023
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 957, 176028
Abstract
No abstract availableKeywords
Funding Information
- Department of Science and Technology, Ministry of Science and Technology, India
- Council of Scientific and Industrial Research, India
- University Grants Commission
- Anusandhan National Research Foundation (TAR/2021/000140)
- Agharkar Research Institute (ZOO-17)
- European Molecular Biology Organization (8979, CRG/2018/001882)
This publication has 47 references indexed in Scilit:
- Autophagy failure in Alzheimer's disease and the role of defective lysosomal acidificationEuropean Journal of Neuroscience, 2013
- Autophagy failure in Alzheimer's disease—locating the primary defectNeurobiology of Disease, 2011
- Tau oligomers and aggregation in Alzheimer’s diseaseJournal of Neurochemistry, 2010
- OLEX2: a complete structure solution, refinement and analysis programJournal of Applied Crystallography, 2009
- Rapamycin and mTOR-independent autophagy inducers ameliorate toxicity of polyglutamine-expanded huntingtin and related proteinopathiesCell Death & Differentiation, 2008
- Autophagy Induction and Autophagosome Clearance in Neurons: Relationship to Autophagic Pathology in Alzheimer's DiseaseThe Journal of Neuroscience, 2008
- Cholinesterase inhibitors for Alzheimer's diseaseCochrane Database of Systematic Reviews, 2006
- Current drug targets for Alzheimer's disease treatmentDrug Development Research, 2002
- A tombstone in Alzheimer's?Nature, 1995
- A new and rapid colorimetric determination of acetylcholinesterase activityBiochemical Pharmacology, 1961